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 ABSTRACT 
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ACETAMINOPHEN REGIMENS ON THE TREATMENT 
 OF POST-ENDODONTIC PAIN 
 
 
Erik D. DeYoung, D.D.S. 
 
Marquette University, 2012 
 
 
Introduction: The purpose of this study was to determine the efficacy of taking 
ibuprofen and acetaminophen at the same time versus alternating the same medications in 
patients with a diagnosis of symptomatic irreversible pulpitis. 
Materials and Methods: Ten patients who presented for root canal therapy with a 
diagnosis of symptomatic irreversible pulpitis were included in this study.  The patients were 
randomly assigned to 2 groups.  Following root canal therapy, the patients in group A were 
instructed to take ibuprofen 600 mg and acetaminophen 1000 mg every six hours.  Patients in 
group B were instructed to take ibuprofen 600 mg, wait three hours, take acetaminophen 1000 
mg, wait three hours, and repeat the cycle.  Patients evaluated their pain levels using a numeric 
rating scale (NRS) at 2, 4, 6, 8, 12, and 24 hours post-operatively. 
Results: The average preoperative pain level was 4.0 ± 2.0 for group A and 4.4 ± 3.05 for 
group B.  The pain levels for group A were 3.4 ± 2.61 at 2 hours, 2.8 ± 1.79 at 4 hours, 2.6 ± 1.52 
at 6 hours, 3.0 ± 2.0 at 8 hours, 2.4 ± 2.61 at 12 hours, and 2.2 ± 2.68 at 24 hours.  The pain 
levels for group B were 2.2 ± 0.84 at 2 hours, 2.0 ± 0.71 at 4 hours, 1.8 ± 0.84 at 6 hours, 2.0 ± 
1.22 at 8 hours, 1.6 ± 0.55 at 12 hours, and 1.4 ± 0.55 at 24 hours. 
 Conclusions: The data shows a trend toward having no significant difference between 
the two test groups. 
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Introduction 
 
 
Many patients who are treated at endodontic practices report pain due to 
irreversible pulpitis.  While root canal therapy aims to eliminate this pain, there can still 
be discomfort following the procedure.  Numerous medications have been used to treat 
this post-endodontic pain including NSAIDs (i.e. ibuprofen), acetaminophen, steroids, 
prescription narcotics, and antibiotics.  This study is a further investigation into how the 
timing of doses of two commonly used over-the-counter pain medications, ibuprofen 
and acetaminophen, might alleviate post-operative pain. 
Pulpitis, as the name implies, is inflammation of the pulp due to caries or the 
restorative process, such as a deep restoration or a crown preparation.  The process of 
pulpal inflammation has been described in detail (Kim, 1990).  Trauma to the pulp 
causes the release of vascular mediators including histamine and serotonin.  These 
mediators then cause an increase in vasodilation and vascular permeability, leading to 
an initial increase in pulpal blood flow followed by a decrease in blood flow.  Also among 
the mediators released following noxious stimuli are prostaglandins.  Prostaglandins, 
especially PGE2, can cause hyperalgesia, vasodilation, and increased vascular 
permeability.  Due to the pulp being a low compliance system, this immune response 
can lead to an increase in pulpal tissue pressure, hypoxia, and pulpal necrosis, all of 
which can produce significant pain.  Root canal therapy aims to remove the pulp, 
thereby eliminating the source of pain.  However, inflammatory mediators (i.e. 
prostaglandins) may still be present in the periapical tissues (Shimauchi et al., 1997).  
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Also, the root canal procedure itself can trigger production of prostaglandins due to the 
trauma of severing the pulp and the irritation of the PDL subsequent to establishing 
patency, cleaning, and shaping (Siqueira and Barnett, 2004).  This inflammatory process 
in the periradicular areas of the tooth after treatment can produce post-operative pain. 
One of the most commonly used pain medications is ibuprofen.  A survey 
published by Mickel, et al. (2006) showed that endodontists recommend ibuprofen 600-
800 mg significantly more than any other pain medication.  Due to the mechanism of 
action, ibuprofen is able to treat both pain and inflammation at the site of injury.  
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID).  This class of drugs, which 
includes aspirin, works by blocking the conversion of arachidonic acid to prostaglandins 
via the cyclooxygenase (COX) -1 and -2 pathways.  By preventing the production of 
prostaglandins, inflammation can be reduced and pain managed.  It has been shown in 
numerous studies that ibuprofen 400-800 mg is more effective than almost all other 
pain medications, including acetaminophen (APAP), narcotics, and combinations of 
narcotics and APAP (Winter et al., 1978; Cooper, 1984; Cooper et al., 1989; Barden et 
al., 2004; Derry et al., 2009; Hersh et al., 2011).  The U.S. Food and Drug Administration 
(FDA) has set the maximum single dose of ibuprofen at 800 mg and the maximum daily 
dose at 3200 mg.  The potential side effects of ibuprofen range from mild to severe and 
include nausea, gastrointestinal bleeding, diarrhea, constipation, headache, dizziness, 
rash, renal impairment, stroke and heart attack.  These adverse reactions, however, are 
rare; the more serious cardiovascular risks are seen only in patients taking long-term 
high doses.  Ibuprofen has also been shown to interfere with the antiplatelet activity of 
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aspirin.  Because the prostaglandin pathway is blocked by ibuprofen, much of the 
arachidonic acid is converted through the still-viable lipoxygenase pathway into 
leukotrienes.  Some leukotrienes are responsible for bronchoconstriction, which can 
lead to an asthma attack in asthmatic patients.  For this reason, those with asthma 
should not take ibuprofen.  
Acetaminophen is another commonly used over-the-counter pain medication.  
While the method of action is not fully understood, it is thought that it generally affects 
pain perception centrally rather than peripherally as ibuprofen and other NSAIDs do.  
Recent work has found that the metabolite AM404 is responsible for all or part of the 
analgesic effects of acetaminophen (Högestätt, 2005).  There has also been speculation 
that acetaminophen has some capacity as a COX-2 inhibitor, but this may be limited at 
the site of inflammation (Hinz et al., 2008).  The FDA recommends the maximum single 
dose be limited to 1000 mg and the daily dose to 4000 mg.  At these levels, adverse 
effects are rare but can include nausea and other stomach issues.  At higher doses, 
APAP can cause acute hepatotoxicity. 
Recently, there has been more evidence supporting a combination of both 
ibuprofen and acetaminophen in the treatment of post-operative pain.  A study by 
Menhinick et al. demonstrated that, following root canal therapy, a combination of 
ibuprofen 600 mg and APAP 1000 mg was more effective than ibuprofen 600 mg alone 
at treating post-operative pain (Menhinick et al, 2004).  Mehlisch et al. (2010) found 
that a combination of ibuprofen 400 mg and APAP 1000mg relieved pain better that a 
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combination of ibuprofen 200 mg and APAP 500 mg, ibuprofen 400 mg alone, or APAP 
1000 mg alone.  The addition of acetaminophen to ibuprofen has an additive effect that 
can preclude the need for narcotic analgesics and thus avoiding the undesired side 
effects (Hargreaves et al., 2005). 
Following root canal therapy, patients can experience post-endodontic pain.  
O’Keefe (1976) reported on the incidence and severity of post-endodontic pain.  He 
found that 50.9% of patients reported no pain, 47.2% reported mild pain, and 1.8% 
reported moderate to severe pain.  Included in this study were patients with all types of 
pulpal diagnoses, so the results cannot be extrapolated to calculate the incidence of 
pain only in patients with symptomatic irreversible pulpitis.  One other significant 
finding from the study is that patients who reported moderate to severe pre-operative 
pain were five times more likely to experience moderate to severe post-operative pain 
than those patients who reported none to mild pre-operative pain. 
While several studies as stated above have shown the efficacy of a combination 
of ibuprofen and acetaminophen, there has not been a study designed to determine if 
differing dosing regimens of these two medications offer better pain relief than others.  
One possibility when alternating the medications is that it will allow the maximum 
effect, which occurs soon after administration, of each drug to be offset.  The peak 
effect of each medication will occur as the effect of the previous medication is 
diminishing (Figure 1).  The other possibility is that the effects of either medication 
could wear off before the next dose of the other medication is to be taken (represented 
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by * in Figure 2).  The same theories could hold true for taking the medications at the 
same time.  The first possibility is that the additive effects of the medications could 
produce sufficient analgesia over a long enough period that the pain relief is always 
greater than the minimum concentrations needed to produce said relief (Figure 3).  The 
second is that the medications, which are metabolized by different processes, could be 
degraded quickly enough that it results in pain relief declining below effective levels 
before the next scheduled dosage (represented by * in Figure 4). 
The aim of this study will be to investigate whether there is a difference in the 
pain relief following root canal therapy on teeth exhibiting symptomatic irreversible 
pulpitis between administering ibuprofen 600 mg and APAP 1000 mg at the same time 
every six hours and alternating the same medications every three hours.  The null 
hypothesis states that there will not be a difference in analgesic effect between 
administering ibuprofen 600 mg and APAP 1000 mg at the same time every six hours, 
and alternating these same medications every three hours.  The alternative hypothesis 
is that either group will experience more profound pain relief than the other. 
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Figure 1. Proposed theory of the benefit of alternating medications.  The effect of the 
second medication (red) begins just prior to the point at which the effect of the first 
medication (blue) is diminishing below the effective level. 
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Figure 2. Proposed theory of the drawback of alternating medications.  The effect of the 
first medication (blue) diminishes below the effective level before the effect of the 
second medication (red) can reach therapeutic doses (noted by *). 
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Figure 3. Proposed theory of the benefit of taking both medications at the same time.  
The purple line represents the additive effect of the medications.  In this case, taking 
both medications at the same time provides enough analgesia over a sufficient amount 
of time to never drop below therapeutic levels. 
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Figure 4. Proposed theory of the drawback of taking both medications at the same time.  
Although the additive effects of the medications (purple) produce a higher level of 
analgesia than either medication alone, the combined effects diminish before the next 
dose is taken (noted by *). 
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Materials and Methods 
 
 
The protocol for this study was approved by the Marquette University 
Institutional Review Board (Protocol HR-2194).  Ten adult patients participated in this 
study.  All patients were determined to be in good health following a review of the 
health history and oral questioning.  The following exclusion criteria were applied: age 
less than 18 years, pregnancy, ibuprofen or acetaminophen use within the last 12 hours, 
allergy to ibuprofen or acetaminophen, diagnosis of a bleeding disorder (i.e. hemophilia 
or Von Willebrand’s disease), liver or kidney disease, peptic ulcer disease, long-term 
corticosteroid use, diagnosis of Inflammatory Bowel Disease (i.e. Ulcerative Colitis or 
Crohn’s Disease).  All patients gave written informed consent. 
The patients in this study all had a diagnosis of symptomatic irreversible pulpitis. 
The diagnosis was determined by testing with Endo-Ice (Hygenic Corp, Akron, OH), an 
electric pulp tester (Analytic Technology Corp, Redmond, WA), and, as necessary, heat 
using gutta percha on a System B tip (SybronEndo, Orange, CA).  If there were any 
indication of advanced pulpal pathosis with periapical involvement, such as a 
periradicular radiolucency or draining sinus tract, the patient was not included in the 
study.  Patients rated their pre-operative pain levels using a numeric rating scale (NRS) 
on a scale from 1 (no pain) to 10 (severe pain) (Figure 5). 
All endodontic procedures were performed by endodontic residents and 
completed in a single visit.  Topical benzocaine (Topex; Sultan Healthcare, Ontario, 
Canada) was applied to the injection sites prior to anesthesia.  All maxillary teeth were  
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Figure 5. The numeric rating scale (NRS) used by patients to determine pain levels. 
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anesthetized using 68-132 mg of 4% articaine with 1:100,000 epinephrine (Septocaine; 
Septodont, Louisville, CO) by buccal and lingual infiltration.  All mandibular teeth were 
anesthetized using 34-68 mg of 2% lidocaine with 1:100,000 epinephrine (Xylocaine; 
Dentsply, York, PA) by inferior alveolar nerve block and 34 mg of 4% articaine with 
1:100,000 epinephrine by buccal infiltration.  If necessary, 51-102 mg of 3% carbocaine 
without epinephrine (Mepivacaine; Carestream Health, Rochester, NY) was 
administered by inferior alveolar nerve block.  Pulpal anesthesia was confirmed by no 
response to Endo-Ice or EPT.  After successful anesthesia, a rubber dam was placed, and 
access into the pulp chamber was achieved.  If purulence or lack of vital tissue was 
found in any canals at this time, the patient was excluded from the study.  Working 
length was determined using a Root ZX II apex locator (J Morita Corp, Tokyo, Japan).  
Copious amounts of 5.25% NaOCl were used as irrigation, and Glyde (Dentsply-Tulsa 
Dental, Tulsa, OK) was used as a canal lubricant.  Each canal was filed to a size 20/.02 
hand file.  The canals were then prepared using rotary instrumentation (RaCe and 
EndoSequence, Brasseler USA, Savannah, GA) in a modified crown-down technique.  The 
final master apical file size was determined according the size and shape of the original 
canal.  Radiographs with the master gutta percha cones in place were used to verify 
working length, and adjustments were made as needed.  All canals were rinsed using 
aqueous 17% EDTA (Roydent, Johnson City, TN) and 5.25% NaOCl using a ProRinse side-
port Luer-Lok needle (Dentsply-Tulsa Dental) and a 6 cc disposable plastic Luer-Lok 
syringe.  The canals were then dried with paper points (EndoSequence, Brasseler USA).  
The master cones were coated with AH Plus sealer (Dentsply-Tulsa Dental).  Obturation 
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was completed using warm vertical compaction by burning down to 3-6 mm from the 
apex using a System B and backfilling using an Obtura II or III Max (Obutra Spartan, 
Fenton, MI).  The pulp chamber was temporized using sterile sponge or cotton pellet 
and either Cavit (3M ESPE AG, Seefeld, Germany) or Fuji Triage (GC America Inc, Alsip, 
IL). 
Following treatment, the patients given two bottles of medications labeled A and 
B.  Bottle A contained 12 liquigel capsules of ibuprofen 200 mg (PL Developments, 
Westbury, NY).  Bottle B contained 8 capsules of quick release acetaminophen 500 mg 
(LNK International Inc, Seattle, WA).  Patients were randomly assigned to one of two 
groups.  Patients in group A were instructed to take three capsules (600 mg) of bottle A 
and two capsules (1000 mg) of bottle B every six hours.  Patients in group B were 
instructed to take three capsules (600 mg) of bottle A, wait three hours, then take two 
capsules (1000 mg) of bottle B, wait three hours and repeat the cycle. 
Patients were given an instruction sheet and an NRS and were instructed to 
record their pain levels at 2, 4, 6, 8, 12, and 24 hours post-operatively.  If the study 
medications were not sufficient in relieving pain, the patients were instructed to call a 
pre-paid cell phone carried by the lead investigator (E.D.D.).  Patients would then be 
prescribed tramadol and instructed to continue the study medications as needed.  If the 
patient developed severe pain or swelling, he or she would be seen clinically and 
evaluated for the need for additional treatment and/or medications, including 
antibiotics.  The patients were contacted the following day and their data recorded. 
14 
 
Results 
 
 
Ten patients participated in the study with 5 patients in each group.  The mean 
pain levels can be found in Table 1 and Figure 6.  The patients in group A (mean age, 
40.2; range, 25-62) consisted of 1 male and 4 females.  The responses from the 
individual patients in group A can be seen in Figure 7.  The patients in group B (mean 
age, 35.0; range, 26-51) consisted of 5 females.  The responses from the individual 
patients in group B can be seen in Figure 8. The average preoperative pain for group A 
was 4.0 ± 2.0.  The pain levels for group A were 3.4 ± 2.61 at 2 hours, 2.8 ± 1.79 at 4 
hours, 2.6 ± 1.52 at 6 hours, 3.0 ± 2.0 at 8 hours, 2.4 ± 2.61 at 12 hours, and 2.2 ± 2.68 at 
24 hours.  The average preoperative pain for group B was 4.4 ± 3.05.  The pain levels for 
group A were 2.2 ± 0.84 at 2 hours, 2.0 ± 0.71 at 4 hours, 1.8 ± 0.84 at 6 hours, 2.0 ± 
1.22 at 8 hours, 1.6 ± 0.55 at 12 hours, and 1.4 ± 0.55 at 24 hours. 
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Time Post-Op (h) Pain Level* 
  Group A Group B 
Pre-Op 4.0 ± 2.0 4.4 ± 3.0 
   2 3.4 ± 2.6 2.2 ± 0.8 
   4 2.8 ± 1.8 2.0 ± 0.7 
   6 2.6 ± 1.5 1.8 ± 0.8 
   8 3.0 ± 2.0 2.0 ± 1.2 
   12 2.4 ± 2.6 1.6 ± 0.5 
   24 2.2 ± 2.7 1.4 ± 0.5 
* Mean ± Standard Deviation 
 
Table 1. Average pain levels reported at each time interval per group. 
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Average pain levels for both groups 
 
Figure 6. The mean pain levels and standard deviations reported for each group. 
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Comparison of individual pain levels in
 
Figure 7. Responses from each individual patient in group A. 
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Comparison of individual pain responses in 
 
Figure 8. Responses from each individual patient in group B. 
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Discussion 
 
 
The data exhibits a trend towards being not significantly different between the 
two treatment groups.  While the data seems to conclude that patients in group B 
experienced greater pain relief than those in group A, it should be noted that the 
standard deviation for group A is much greater than that of group B.  Because of the 
variability in the small sample size, it cannot be concluded that the difference will be 
significant.  The larger standard deviation is likely due to one patient in group A who 
reported pain levels that were much greater than any other participant (Figure 6).  It is 
possible that the patient reacted more severely to treatment than the other patients.  
This patient, however, did not feel the need to contact the investigator for prescription 
medication.  Although using the NRS should normalize variances, patients perceive pain 
differently.  While some patients may report a certain level of pain as 2, others may 
perceive that same pain as 4.  This subjective variance may be negated with an increase 
in the number of participants.  Additionally, it is not known how the slight difference in 
gender makeup between the two groups contributed to the findings. 
It could be expected that if a difference were to exist, it would be recognizable at 
either the 4- or 6-hour response time.  One explanation as to why no significant 
difference is seen between the two test groups is that the medications have a longer 
additive effect than 6 hours.  This is supported by other research (Menhinick et al., 
2004; Mehlisch et al., 2010).  It is expected that the pain levels be low when alternating 
the medications as the peak effect of one drug is only 3 hours apart from the peak of 
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the drug.  When taking both acetaminophen and ibuprofen at the same time, the peak 
effect could be much greater initially and the decrease in effect more gradual than 
taking either medication alone (Figure 3).  In this way, the therapeutic levels may be 
maintained above the threshold at which the patient would feel pain during the entire 6 
hours before the next dose. 
It is difficult to separate the causes of pain in cases of irreversible pulpitis and 
necrosis.  Necrotic teeth have a bacterial component that could have a significant 
impact on the amount of pain experienced following root canal therapy.  This bacterial 
aspect adds an additional layer to the inflammatory reaction, one not mediated solely 
by inflammatory mediators but also by the immune system and its goal of eliminating 
the bacteria present.  A recent study by Wells et al. (2011) showed that there was no 
difference in pain relief following root canal therapy on necrotic teeth between groups 
taking either ibuprofen 600 mg alone or a combination of ibuprofen 600 mg and APAP 
1000 mg.  This information can be compared with the results of the Menhinick et al. 
(2004) study to suggest that there may be a compounding factor in necrotic cases in 
relation to the cause of pain. 
Many previous studies investigating pain medications evaluated pain after 
cleaning and shaping but before obturation (Torabinejad et al., 1994; Menhinick et al., 
2004; Wells et al., 2010).  Root canal therapy consists also of obturation which can be a 
source of post-operative pain (Harrison et al., 1983).  This study was aiming to be more 
complete in terms of pain relief following a root canal since all treatment was 
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performed in a single visit.  In recent years, a majority of endodontists have begun to 
perform single step non-surgical root canal therapy (Inamoto et al., 2002).  There have 
also been several studies that investigated the pain following single- or multiple-step 
root canals (Roane et al., 1983; DiRenzo et al., 2002; ElMubarak et al., 2010; Wang et al, 
2010).  Most investigators found there was no difference between single and multiple 
visit non-surgical root canal therapy in terms of the level of pain experienced by the 
patient.  Roane et al. determined that there was actually less pain following single-step 
endodontics when compared to two-step endodontics.  Because there is relatively little 
difference in pain between single and multiple visit root canals, this study is applicable 
for most practitioners.   
The duration of evaluation of pain in this study was 24 hours.  While some 
studies have investigated duration of pain for longer (Wells et al., 2011), Harrison et al. 
(1983) found that the highest incidence and degree of pain following obturation was in 
the first 24 hours.  While post-operative pain is not limited to only 24 hours, the level of 
pain should decrease significantly after the first day.  To treat pain after this initial 
period, patients can be advised to continue medication for 2-3 days following the 
procedure (Hargreaves and Abbott, 2005). 
Several recent studies have shown the efficacy of liquigel ibuprofen (Hersh et al, 
2000; Olson et al, 2001; Doyle et al., 2002).  Hersh et al. demonstrated that liquigel 
ibuprofen had a faster onset of pain relief and greater peak pain relief.  The theory may 
also apply to quick release acetaminophen.  These capsules are designed to break open 
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quickly in the stomach, allowing for faster delivery of the drug.  While faster delivery 
leads to faster onset of pain relief, there have been no studies investigating whether the 
duration of pain relief is affected.   
As the results of the study are showing a trend towards a non-significant 
difference, it would be reasonable to suggest that patients take both medications at the 
same time.  This schedule would likely increase patient compliance and reduce post-
operative complications.  Patients are more likely to miss a dose if they need to 
remember to take one every three hours as opposed to every six hours.  If a patient 
forgets to take the medication at a certain time, there could be an increase in the pain, 
which could lead a patient to schedule an emergency visit or request stronger (i.e. 
narcotic) pain medications. 
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Conclusion 
 
 
The results of this study indicate that there is trend toward there being no 
difference in pain relief between taking ibuprofen 600 mg and acetaminophen 1000 mg 
together or alternating the same medications.  Further studies with an increased 
number of subjects are needed to either validate or refute these findings. 
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